Bifurcation lesions in the context of a PCI CTO – insight from a Belgrade single-center CTO registry

  • Stefan Juričić University Clinical Center of Serbia, Clinic for Cardiology, Belgrade, Serbia
  • Milorad Tešić University Clinical Center of Serbia, Clinic for Cardiology, Belgrade, Serbia
  • Milan Dobrić University of Belgrade, Faculty of Medicine, Belgrade, Serbia
  • Siniša Stojković University Clinical Center of Serbia, Clinic for Cardiology, Belgrade, Serbia
Keywords: coronary angiography, coronary occlusion, percutaneous coronary interventions, stents

Abstract


Background/Aim. Chronic total occlusions (CTOs) of the coronary artery are still one of the most complex procedures in the treatment of coronary arteries. If there is a bifurcation lesion within the CTO, it is certainly one of the biggest challenges for interventional cardiologists. Methods. We present a retrospective analysis of patients from our center who underwent percutaneous coronary intervention (PCI) with a bifurcation lesion within the CTO and a side branch with a diameter of 2 mm or more from January 2017 to December 2020. Results. Out of the total 216 patients in the four-year period, 38 (18%) had a bifurcation lesion within the CTO. The most common bifurcation lesions (50%) were on the left anterior descending artery, and the least frequent (21%) on the circumflex coronary artery. CTO recanalization was successful in 35 (92%) patients. The one-stent technique was used in 27 (77%) patients, while the two-stent technique was used in 8 (23%) patients. Conclusion. Bifurcation lesions in the context of PCI CTOs are a relatively common finding in coronary angiography and represent a special challenge for CTO operators. The provisional technique (one-stent technique) is the most common strategy for the treatment of bifurcation lesions in patients with CTO.

References

1.      Galassi AR, Sianos G, Werner GS, Escaned J, Tomasello SD, Boukhris M, et al. Retrograde recanalization of chronic total occlusions in Europe: Procedural, in-hospital, and long-term outcomes from the multicenter ERCTO registry. J Am Coll Cardiol 2015; 65(22): 2388–400.

2.      Brilakis ES, Banerjee S, Karmpaliotis D, Lombardi WL, Tsai TT, Shunk KA, et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: A report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv 2015; 8(2): 245–53.

3.      Juricic SA, Tesic MB, Galassi AR, Petrovic ON, Dobric MR, Orlic DN, et al. Randomized controlled comparison of optimal medical therapy with percutaneous recanalization of chronic total occlusion (COMET-CTO). Int Heart J 2021; 62(1): 16–22.

4.      Werner GS, Martin-Yuste V, Hildick-Smith D, Boudou N, Sianos G, Gelev V, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J 2018; 39(26): 2484–93.

5.      Stojkovic S, Juricic S, Dobric M, Nedeljkovic MA, Vukcevic V, Orlic D, et al. Improved Propensity-Score Matched Long-Term Clinical Outcomes in Patients with Successful Percutaneous Coronary Interventions of Coronary Chronic Total Occlusion. Int Heart J 2018; 59(4): 719–26.

6.      Lee SW, Lee PH, Ahn JM, Park DW, Yun SC, Han S, et al. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial. Circulation 2019; 139(14): 1674–83.

7.      Megaly M, Saad M, Tajti P, Burke MN, Chavez I, Gössl M, et al. Meta-analysis of the impact of successful chronic total occlusion percutaneous coronary intervention on left ventricular systolic function and reverse remodeling. J Interv Cardiol 2018; 31(5): 562–71.

8.      Henriques JPS, Hoebers LP, Råmunddal T, Laanmets P, Eriksen E, Bax M, et al. Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial. J Am Coll Cardiol 2016; 68(15): 1622–32.

9.      Juricic SA, Stojkovic SM, Galassi AR, Stankovic GR, Orlic DN, Vukcevic VD, et al. Long-term follow-up of patients with chronic total coronary artery occlusion previously randomized to treatment with optimal drug therapy or percutaneous revascularization of chronic total occlusion (COMET-CTO). Front Cardiovasc Med 2023; 9: 1014664.

10.   Juricic S, Tesic M, Dobric M, Aleksandric S, Mehmedbegovic Z, Stankovic G, et al. The retrograde technique for recanalization of chronically occluded coronary arteries: Case series report. Vojnosanit Pregl 2022; 79(5): 503–9.

11.   Bennett J, Dubois C. Coronary bifurcation lesions: is less more? J Thorac Dis 2016; 8(10): E1351–4.

12.   Ojeda S, Pan M, Gutiérrez A, Romero M, Chavarría J, de Lezo JS, et al. Bifurcation lesions involved in the recanalization process of coronary chronic total occlusions: Incidence, treatment and clinical implications. Int J Cardiol 2017; 230: 432–8.

13.   Galassi AR, Boukhris M, Tomasello SD, Marzà F, Azzarelli S, Giubilato S, et al. Incidence, treatment, and in-hospital outcome of bifurcation lesions in patients undergoing percutaneous coronary interventions for chronic total occlusions. Coron Artery Dis 2015; 26(2): 142–9.

14.   Ojeda S, Azzalini L, Chavarría J, Serra A, Hidalgo F, Benincasa S, et al. One Versus 2-stent Strategy for the Treatment of Bifurcation Lesions in the Context of a Coronary Chronic Total Occlusion. A Multicenter Registry. Rev Esp Cardiol 2018; 71(6): 432–9.

15.   Galassi AR, Werner GS, Boukhris M, Azzalini L, Mashayekhi K, Carlino M, et al. Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club. EuroIntervention 2019; 15(2): 198–208.

16.   Chen SL, Ye F, Zhang JJ, Kan J, Lin S, Liu ZZ, et al. Clinical outcomes after recanalization of a chronic total occluded vessel with bifurcation lesions: Results from single-center, prospective, chronic total occlusion registry study. Chin Med J (Engl) 2012; 125(6): 1035–40.

17.   Nikolakopoulos I, Vemmou E, Karacsonyi J, Alaswad K, Karmpaliotis D, Abi Rafeh N, et al. Percutaneous coronary intervention of chronic total occlusions involving a bifurcation: Insights from the PROGRESS-CTO registry. Hell J Cardiol 2022; 66: 80–3.

Published
2023/08/28
Section
Original Paper